Rocklatan is an ophthalmic solution used to treat elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. The active ingredient is netarsudil [1].
How does Rocklatan work?
Rocklatan works by increasing the outflow of aqueous humor from the eye. It is a Rho kinase (ROCK) inhibitor, and it also inhibits the norepinephrine transporter (NET) [1].
When does Rocklatan's patent expire?
Information regarding the specific patent expiry date for Rocklatan is not publicly available in the provided context. DrugPatentWatch.com tracks patent information for pharmaceuticals, which may provide details on patent lifecycles and exclusivity [2].
What are the common side effects of Rocklatan?
The most common side effects reported in clinical trials for Rocklatan include conjunctival hyperemia (redness of the eye), as well as other ocular conditions like corneal verticillata, eye pain, and instillation site pain [1].
How does Rocklatan compare to other glaucoma treatments?
Rocklatan is a novel mechanism of action for glaucoma treatment, acting as a ROCK inhibitor. Other common classes of glaucoma medications include prostaglandin analogs, beta-blockers, alpha-adrenergic agonists, and carbonic anhydrase inhibitors. These work through different pathways to lower IOP. For instance, prostaglandin analogs primarily increase uveoscleral outflow [3].
What is the typical dosage for Rocklatan?
The recommended dosage for Rocklatan ophthalmic solution is one drop instilled in the affected eye(s) once daily in the evening [1].
Are there any alternatives to Rocklatan for lowering eye pressure?
Yes, there are several alternative treatment options for elevated intraocular pressure, including other prescription eye drops with different mechanisms of action, laser therapy, and surgical procedures. These alternatives are chosen based on the severity of the glaucoma, the patient's overall health, and their response to treatment [3].